Results 111 to 120 of about 18,516 (241)
Pharmacotherapy for comorbid antisocial personality and obsessive-compulsive disorder: A case report
Anastasia Jankovsky +2 more
openalex +1 more source
ABSTRACT Autism and personality disorders, including borderline personality disorder (BPD), demonstrate high levels of co‐occurrence. Autistic individuals are more likely to experience social adversity and exhibit heightened reactivity to stressors, while social adversity is a well‐established precursor to BPD.
Ellie Roberts, Lucy Scott
wiley +1 more source
Antisocial personality disorder: new directions [PDF]
Jessica Yakeley, Nadine Ravinet
openalex +1 more source
Oxytocin effects on amygdala reactivity to angry faces in males and females with antisocial personality disorder. [PDF]
Jeung-Maarse H +4 more
europepmc +1 more source
ABSTRACT Adverse childhood experiences (ACEs) are a well‐established risk factor for a wide range of mental health conditions, including personality disorder (PD). Yet, few studies have explored the relationship between ACEs and dimensional models of PD using the ICD‐11 framework.
Rachael C. Martin, Martin Sellbom
wiley +1 more source
Antisocial personality disorder in group therapy, kindling pro-sociality and mentalizing. [PDF]
Morken KTE +4 more
europepmc +1 more source
Abstract This article presents the findings of a longitudinal study on the influence of contextual factors on students' social–emotional development. A total of 1535 students in Grades 5 and 6 were examined at three points of measurement (1 year). The aim was to assess the connection between social–emotional development (i.e., prosocial behaviour ...
Mathias Krammer +2 more
wiley +1 more source
Genome-wide association study of antisocial personality disorder diagnostic criteria provides evidence for shared risk factors across disorders. [PDF]
Li W +11 more
europepmc +1 more source
Child and Adolescent Mental Health, Volume 31, Issue 1, Page 84-86, February 2026.
Marinos Kyriakopoulos +3 more
wiley +1 more source
Nine out of ten inpatients treated for various types of substance use disorders had a Vitamin D deficiency. Vitamin D deficiency was associated with lower calcium plasma levels, higher BMI and craving levels for both substance and food. Vitamin D supplementation should be part of the treatment regimen of people with substance use disorders.
Luca Pavirani +5 more
wiley +1 more source

